Month: June 2018

Keeping in line with the company’s product expansion strategy, Bruker Corporation BRKR recently introduced a broad line of mass spectrometry products and workflows at the ASMS (American Society for Mass Spectrometry) conference. The company claims these products to act as breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in biopharma applications and in applied toxicology and forensics markets. The Launches The mass spectrometry products launched by the company are as follows: The company has introduced scimaXTM Magnetic Resonance Mass Spectrometer (MRMS),which comes under Phenomics and Proteomics Innovations. […]

Credit rating giant Moody’s Investors Service has upgraded The Hartford Financial Services Group, Inc. ’s HIG long-term debt ratings from senior to Baa 1 from Baa2. […]

On May 31, 2018, we issued an updated research report on Boston Scientific Corporation BSX . The company is gaining traction in the emerging markets, particularly in the BRIC zone. […]

Moody’s Investors Service, a subsidiary of Moody’s Corporation, recently gave ratings to Assurant, Inc. AIZ and its property and casualty (P&C) as well as life insurance operating subsidiaries. This rating action followed the closure of Assurant’s buyout of The Warranty Group from TPG Capital for about $2.5 billion. […]

Community Health Systems, Inc. CYH has completed the sale of 60-bed Byrd Regional Hospital and its associated assets to the subsidiaries of the Allegiance Health Management. […]

Southwest Gas Corporation SWX filed an application with the Public Utilities Commission of Nevada to increase statewide overall general rate of $32.5 million including the benefit of reduced tax liability associated with the Tax Cuts and Jobs Act of 2017 for its Nevada service areas. Through this rate increase filing, the company intends to recoup the capital investment made since the last rate filing in April 2012 in Nevada as well as for the planned capital investment going ahead. The previous rate hike came into effect from November 2012, which raised the company’s annual revenues by $7 million, lower than the filing rate hike of $26.9 million […]

Emerson Electric Company EMR recently announced that its unit, Vilter Manufacturing has engineered a new suite of products that are likely to be launched in the spring. Vilter’s new suite of products comes up with low global warming potential (GWP) and helps in reduction of ammonia, thus offering a sustainable and safe cold chain. Notably, the company’s new suite of products incorporates the use of ammonia CO2 cascade system and enables its customers to reduce operating costs […]

Iconix Brand Group, Inc. ’s ICON strong footing in the international arena has been quite a boon to the company’s performance for a while. Well, the company boasts solid retail partnerships and licensees worldwide. […]

Tyson Foods, Inc TSN recently entered into an agreement with private-equity firm — Kohlberg & Company — to sell its Sara Lee Frozen Bakery and Van’s businesses. The deal will include the sale of brands such as Chef Pierre, Bistro Collection, Van’s brands and license usage rights of Sara Lee brand across certain channels. […]

The J. M. Smucker Company SJM is slated to release fourth-quarter fiscal 2018 results on Jun 7 […]

Verizon Communications Inc. VZ announced stronger target-specific support preparations for the upcoming hurricane season. The announcement included a detailed list of the measures that the company intends to take during this period. […]

FactSet Research Systems Inc. FDS opened its Shanghai office on May 31. […]

U.S. Cellular Corporation USM has come up with one of its biggest deals of the year. […]

Merck & Co., Inc. ’s MRK PD-L1 inhibitor, Keytruda ruled at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago as the drug giant presented additional data from two pivotal lung cancer studies on the drug. Merck presented additional data from the pivotal KEYNOTE-042 study in patients with locally advanced or metastatic nonsquamous or squamous non-small cell lung cancer (NSCLC) whose tumors express PD-L1 protein levels of 1 percent or greater (TPS of ≥1 percent). […]

The thriving U.S. economy should benefit Visa Inc. […]